NP39722f Lenalidomide

  • The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

F14: Notice for changes or additional information

Notice identifier: 2022/S 000-018399

Procurement identifier (OCID): ocds-h6vhtk-034e87

Published 5 July 2022, 4:25pm



Section one: Contracting authority/entity

one.1) Name and addresses

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

Contact

Ruaridh Armitage

Email

ruaridh.armitage@nhs.scot

Telephone

+44 1698794410

Country

United Kingdom

NUTS code

UKM - Scotland

Internet address(es)

Main address

http://www.nhsscotlandprocurement.scot.nhs.uk/

Buyer's address

http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NP39722f Lenalidomide

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

This Framework Agreement is for the supply of Lenalidomide to health boards across NHS Scotland. Full details is contained in section II.2 of this notice.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2022/S 022-190705


Section seven. Changes

seven.1) Information to be changed or added

seven.1.2) Text to be corrected in the original notice

Section number

IV.2.2

Place of text to be modified

Time limit

Instead of
Date

8 July 2022

Local time

12:00pm

Read
Date

12 July 2022

Local time

12:00pm

Section number

IV.2.7

Place of text to be modified

Conditions for opening of tenders

Instead of
Date

8 July 2022

Local time

12:00pm

Read
Date

12 July 2022

Local time

12:00pm

seven.2) Other additional information

In light of the recent MHRA approval of the NHS Pathfinder Platform, Potential Framework Participants who intend to offer this platform as part of their tender submission, may submit a bid detailing their implementation plan and timeline. Where a Framework Participant intends to utilise the NHS Pathfinder Platform, they will be prohibited from supplying Goods, under the Framework until such time as a final inspection and approval of the Platform has been completed by the MHRA.

Potential Framework Participants, should still complete and upload Appendices B,C & D in relation to the NHS Pathfinder Platform.

The tender submission deadline will be extended to Tuesday 12th July 12 Noon.